ArticleFrontiers in immunology2023

Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.